SAN FRANCISCO — In a rare win for plaintiffs involving the Class Action Fairness Act, the U.S. Court of Appeals for the Ninth Circuit ruled Tuesday that a mass pharmaceutical action involving hundreds of individual plaintiffs can stay in a California state court, notwithstanding the objections of defendant Teva Pharmaceuticals USA, amicus U.S. Chamber of Commerce and a dissenting judge.
The court ruled that a coordinated mass action involving 1,500 individual plaintiffs does not belong in federal court because the four plaintiff firms said they were joining the cases together primarily for pretrial purposes. Dissenting Judge Ronald Gould said the case is exactly the type designated for federal court, regardless of how the plaintiffs characterized it.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
